XTX Topco’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

XTX Topco’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,414	Closed	-$201K	–	2484
2023 Q4	$201K	Buy	+3,414	New	+$192K	0.04%	965
2022 Q1	–	Sell	-2,655	Closed	-$389K	–	1021
2021 Q4	$389K	Buy	+2,655	New	+$412K	0.22%	128
2021 Q2	–	Sell	-3,150	Closed	-$540K	–	1165
2021 Q1	$540K	Buy	+3,150	New	+$624K	0.26%	74

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

XTX Topco's MRTX Position: Q1 2024 in Review

XTX Topco sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 3,414 shares — an estimated $201K sold.

XTX Topco first reported a position in MRTX in Q1 2021 and held it in 3 quarters. The position peaked at $540K in Q1 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

XTX Topco reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
XTX Topco sold 3,414 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $201K.
XTX Topco first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
XTX Topco's Mirati Therapeutics, Inc. Common Stock position peaked at $540K in Q1 2021.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on XTX Topco's 13F filing for Q1 2024, filed 13 May 2024.